_id
6919e66a3c536f8df2318185
Ticker
CREO.LSE
Name
Creo Medical Group PLC
Exchange
LSE
Address
Creo House, Chepstow, United Kingdom, NP16 5UH
Country
UK
Sector
Healthcare
Industry
Medical Devices
Currency
GBX
Website
https://www.creomedical.com
Description
Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develps CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices delivered through an endoscope. The company also offers Speedboat Inject, an energy multimodal instrument for endoscopy; MicroBlate Fine, a microwave needle ablation device; MicroBlate Flex, a microwave ablation device designed for soft tissue ablation; and SpydrBlade Flex, a multi-modal endoscopic scissor-type device. In addition, it provides endotherapy accessories comprising injection needles, haemostatic clips, snares, and forceps, as well as other products for gastroenterology, pulmonology, and urology. Further, the company offers products for diagnostic, therapeutic, and hygiene purposes. Creo Medical Group PLC was founded in 2003 and is headquartered in Chepstow, the United Kingdom.
Last Close
101500
Volume
185178
Current Price
10.84
Change
-2.463054187192118
Last Updated
2025-12-29T15:11:41.743Z
Image
https://logo.clearbit.com/www.creomedical.com
Ipo Date
-
Market Cap
41866040
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-06-30
Revenue
2200000
Cost Of Revenue
1200000
Gross Profit
1000000
Operating Expenses
-15200000
Operating Income
-10000000
Interest Expense
100000
Pretax Income
16100000
Net Income
16900000
Eps
0.040660354764915516
Dividends Per Share
-
Shares Outstanding
412473319
Income Tax Expense
800000
EBITDA
-9500000
Operating Margin
-454.54545454545456
Total Other Income Expense Net
26100000
Cash
20500000
Short Term Investments
-
Receivables
3400000
Inventories
3200000
Total Current Assets
31700000
Property Plant Equipment
3600000
Total Assets
68800000
Payables
3600000
Short Term Debt
2300000
Long Term Debt
-
Total Liabilities
7900000
Equity
60900000
Bs_currency_symbol
GBP
Depreciation
500000
Change In Working Capital
-1500000
Cash From Operations
15600000
Capital Expenditures
0
Cash From Investing
-3300000
Cash From Financing
-600000
Net Change In Cash
10700000
Cf_currency_symbol
-
PE
-
PB
73.98224920985221
ROE
27.750410509031198
ROA
24.563953488372093
FCF
15600000
Fcf Percent
7.090909090909091
Piotroski FScore
3
Health Score
85
Deep Value Investing Score
8.5
Defensive Investing Score
7
Dividend Investing Score
3
Economic Moat Investing Score
10
Garp Investing Score
5.5
Growth Investing Score
4
Momentum Investing Score
4
Net Net Investing Score
4.5
Quality Investing Score
8.5
Value Investing Score
8
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
2200000
Quarters > 0 > income Statement > cost Of Revenue
1200000
Quarters > 0 > income Statement > gross Profit
1000000
Quarters > 0 > income Statement > operating Expenses
-15200000
Quarters > 0 > income Statement > operating Income
-10000000
Quarters > 0 > income Statement > interest Expense
100000
Quarters > 0 > income Statement > pretax Income
16100000
Quarters > 0 > income Statement > net Income
16900000
Quarters > 0 > income Statement > eps
0.040660354764915516
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
415638282
Quarters > 0 > income Statement > income Tax Expense
800000
Quarters > 0 > income Statement > EBITDA
-9500000
Quarters > 0 > income Statement > operating Margin
-454.54545454545456
Quarters > 0 > income Statement > total Other Income Expense Net
26100000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
20500000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
3400000
Quarters > 0 > balance Sheet > inventories
3200000
Quarters > 0 > balance Sheet > total Current Assets
31700000
Quarters > 0 > balance Sheet > property Plant Equipment
3600000
Quarters > 0 > balance Sheet > total Assets
68800000
Quarters > 0 > balance Sheet > payables
3600000
Quarters > 0 > balance Sheet > short Term Debt
2300000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
7900000
Quarters > 0 > balance Sheet > equity
60900000
Quarters > 0 > balance Sheet > currency_symbol
GBP
Quarters > 0 > cash Flow > net Income
16900000
Quarters > 0 > cash Flow > depreciation
500000
Quarters > 0 > cash Flow > change In Working Capital
-1500000
Quarters > 0 > cash Flow > cash From Operations
15600000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-3300000
Quarters > 0 > cash Flow > cash From Financing
-600000
Quarters > 0 > cash Flow > net Change In Cash
10700000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
0.040660354764915516
Quarters > 0 > ratios > PB
73.98224920985221
Quarters > 0 > ratios > ROE
27.750410509031198
Quarters > 0 > ratios > ROA
24.563953488372093
Quarters > 0 > ratios > FCF
15600000
Quarters > 0 > ratios > Piotroski FScore
3
Quarters > 0 > ratios > fcf Percent
7.090909090909091
Quarters > 0 > health Score
85
Quarters > 1 > quarter
2024-06-30
Quarters > 1 > income Statement > revenue
15200000
Quarters > 1 > income Statement > cost Of Revenue
8000000
Quarters > 1 > income Statement > gross Profit
7200000
Quarters > 1 > income Statement > operating Expenses
20900000
Quarters > 1 > income Statement > operating Income
-13700000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-13800000
Quarters > 1 > income Statement > net Income
-12300000
Quarters > 1 > income Statement > eps
-0.03400946735091134
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
361664000
Quarters > 1 > income Statement > income Tax Expense
-1500000
Quarters > 1 > income Statement > EBITDA
-11800000
Quarters > 1 > income Statement > operating Margin
-90.13157894736842
Quarters > 1 > income Statement > total Other Income Expense Net
-100000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
9800000
Quarters > 1 > balance Sheet > short Term Investments
-200000
Quarters > 1 > balance Sheet > receivables
9900000
Quarters > 1 > balance Sheet > inventories
8500000
Quarters > 1 > balance Sheet > total Current Assets
32100000
Quarters > 1 > balance Sheet > property Plant Equipment
8500000
Quarters > 1 > balance Sheet > total Assets
69300000
Quarters > 1 > balance Sheet > payables
5400000
Quarters > 1 > balance Sheet > short Term Debt
3500000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
21900000
Quarters > 1 > balance Sheet > equity
47400000
Quarters > 1 > balance Sheet > currency_symbol
GBP
Quarters > 1 > cash Flow > net Income
-12300000
Quarters > 1 > cash Flow > depreciation
1800000
Quarters > 1 > cash Flow > change In Working Capital
-1800000
Quarters > 1 > cash Flow > cash From Operations
-13500000
Quarters > 1 > cash Flow > capital Expenditures
500000
Quarters > 1 > cash Flow > cash From Investing
14900000
Quarters > 1 > cash Flow > cash From Financing
5500000
Quarters > 1 > cash Flow > net Change In Cash
6800000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.03400946735091134
Quarters > 1 > ratios > PB
82.70965738396625
Quarters > 1 > ratios > ROE
-25.949367088607595
Quarters > 1 > ratios > ROA
-17.74891774891775
Quarters > 1 > ratios > FCF
-14000000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-0.9210526315789473
Quarters > 1 > health Score
26
Quarters > 2 > quarter
2023-12-31
Quarters > 2 > income Statement > revenue
15100000
Quarters > 2 > income Statement > cost Of Revenue
7300000
Quarters > 2 > income Statement > gross Profit
7800000
Quarters > 2 > income Statement > operating Expenses
19200000
Quarters > 2 > income Statement > operating Income
-11800000
Quarters > 2 > income Statement > interest Expense
300000
Quarters > 2 > income Statement > pretax Income
-11300000
Quarters > 2 > income Statement > net Income
-10100000
Quarters > 2 > income Statement > eps
-0.02809264354159429
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
359524727
Quarters > 2 > income Statement > income Tax Expense
-1200000
Quarters > 2 > income Statement > EBITDA
-9300000
Quarters > 2 > income Statement > operating Margin
-78.1456953642384
Quarters > 2 > income Statement > total Other Income Expense Net
500000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
3000000
Quarters > 2 > balance Sheet > short Term Investments
15500000
Quarters > 2 > balance Sheet > receivables
7900000
Quarters > 2 > balance Sheet > inventories
8100000
Quarters > 2 > balance Sheet > total Current Assets
37900000
Quarters > 2 > balance Sheet > property Plant Equipment
9100000
Quarters > 2 > balance Sheet > total Assets
76600000
Quarters > 2 > balance Sheet > payables
1300000
Quarters > 2 > balance Sheet > short Term Debt
3100000
Quarters > 2 > balance Sheet > long Term Debt
4400000
Quarters > 2 > balance Sheet > total Liabilities
16800000
Quarters > 2 > balance Sheet > equity
59800000
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
-10100000
Quarters > 2 > cash Flow > depreciation
1700000
Quarters > 2 > cash Flow > change In Working Capital
-1500000
Quarters > 2 > cash Flow > cash From Operations
-6400000
Quarters > 2 > cash Flow > capital Expenditures
800000
Quarters > 2 > cash Flow > cash From Investing
-1200000
Quarters > 2 > cash Flow > cash From Financing
-800000
Quarters > 2 > cash Flow > net Change In Cash
-8500000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.02809264354159429
Quarters > 2 > ratios > PB
65.17137191772575
Quarters > 2 > ratios > ROE
-16.88963210702341
Quarters > 2 > ratios > ROA
-13.185378590078328
Quarters > 2 > ratios > FCF
-7200000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.4768211920529801
Quarters > 2 > health Score
27
Quarters > 3 > quarter
2023-06-30
Quarters > 3 > income Statement > revenue
15700000
Quarters > 3 > income Statement > cost Of Revenue
9900000
Quarters > 3 > income Statement > gross Profit
5800000
Quarters > 3 > income Statement > operating Expenses
19200000
Quarters > 3 > income Statement > operating Income
-13400000
Quarters > 3 > income Statement > interest Expense
100000
Quarters > 3 > income Statement > pretax Income
-13200000
Quarters > 3 > income Statement > net Income
-11600000
Quarters > 3 > income Statement > eps
-0.04352980649087204
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
266484070
Quarters > 3 > income Statement > income Tax Expense
-1600000
Quarters > 3 > income Statement > EBITDA
-11400000
Quarters > 3 > income Statement > operating Margin
-85.35031847133759
Quarters > 3 > income Statement > total Other Income Expense Net
200000
Quarters > 3 > income Statement > currency_symbol
GBP
Quarters > 3 > balance Sheet > cash
11500000
Quarters > 3 > balance Sheet > short Term Investments
15000000
Quarters > 3 > balance Sheet > receivables
14600000
Quarters > 3 > balance Sheet > inventories
8000000
Quarters > 3 > balance Sheet > total Current Assets
49100000
Quarters > 3 > balance Sheet > property Plant Equipment
9700000
Quarters > 3 > balance Sheet > total Assets
88700000
Quarters > 3 > balance Sheet > payables
7500000
Quarters > 3 > balance Sheet > short Term Debt
3600000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
19700000
Quarters > 3 > balance Sheet > equity
69000000
Quarters > 3 > balance Sheet > currency_symbol
GBP
Quarters > 3 > cash Flow > net Income
-11600000
Quarters > 3 > cash Flow > depreciation
1700000
Quarters > 3 > cash Flow > change In Working Capital
-4000000
Quarters > 3 > cash Flow > cash From Operations
-14900000
Quarters > 3 > cash Flow > capital Expenditures
500000
Quarters > 3 > cash Flow > cash From Investing
-17400000
Quarters > 3 > cash Flow > cash From Financing
30600000
Quarters > 3 > cash Flow > net Change In Cash
-1597000
Quarters > 3 > cash Flow > currency_symbol
GBP
Quarters > 3 > ratios > PE
-0.04352980649087204
Quarters > 3 > ratios > PB
41.8650336057971
Quarters > 3 > ratios > ROE
-16.81159420289855
Quarters > 3 > ratios > ROA
-13.077790304396844
Quarters > 3 > ratios > FCF
-15400000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-0.9808917197452229
Quarters > 3 > health Score
26
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
4000000
Annuals > 0 > income Statement > cost Of Revenue
2100000
Annuals > 0 > income Statement > gross Profit
1900000
Annuals > 0 > income Statement > operating Expenses
30700000
Annuals > 0 > income Statement > operating Income
-28800000
Annuals > 0 > income Statement > interest Expense
400000
Annuals > 0 > income Statement > pretax Income
-29000000
Annuals > 0 > income Statement > net Income
-28700000
Annuals > 0 > income Statement > eps
-0.07935542381879314
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
361664000
Annuals > 0 > income Statement > income Tax Expense
-1200000
Annuals > 0 > income Statement > EBITDA
-26100000
Annuals > 0 > income Statement > operating Margin
-720
Annuals > 0 > income Statement > total Other Income Expense Net
-200000
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
8700000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
1300000
Annuals > 0 > balance Sheet > inventories
2700000
Annuals > 0 > balance Sheet > total Current Assets
56400000
Annuals > 0 > balance Sheet > property Plant Equipment
5900000
Annuals > 0 > balance Sheet > total Assets
65000000
Annuals > 0 > balance Sheet > payables
900000
Annuals > 0 > balance Sheet > short Term Debt
2400000
Annuals > 0 > balance Sheet > long Term Debt
1900000
Annuals > 0 > balance Sheet > total Liabilities
22600000
Annuals > 0 > balance Sheet > equity
42400000
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
-27800000
Annuals > 0 > cash Flow > depreciation
2500000
Annuals > 0 > cash Flow > change In Working Capital
-100000
Annuals > 0 > cash Flow > cash From Operations
-22200000
Annuals > 0 > cash Flow > capital Expenditures
400000
Annuals > 0 > cash Flow > cash From Investing
15300000
Annuals > 0 > cash Flow > cash From Financing
16200000
Annuals > 0 > cash Flow > net Change In Cash
9300000
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
-0.07935542381879314
Annuals > 0 > ratios > PB
84.01864150943396
Annuals > 0 > ratios > ROE
-67.68867924528303
Annuals > 0 > ratios > ROA
-44.15384615384615
Annuals > 0 > ratios > FCF
-22600000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-5.65
Annuals > 0 > health Score
22
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
30800000
Annuals > 1 > income Statement > cost Of Revenue
15500000
Annuals > 1 > income Statement > gross Profit
15300000
Annuals > 1 > income Statement > operating Expenses
40100000
Annuals > 1 > income Statement > operating Income
-24800000
Annuals > 1 > income Statement > interest Expense
400000
Annuals > 1 > income Statement > pretax Income
-24500000
Annuals > 1 > income Statement > net Income
-21700000
Annuals > 1 > income Statement > eps
-0.06932809912361647
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
313004399
Annuals > 1 > income Statement > income Tax Expense
-2800000
Annuals > 1 > income Statement > EBITDA
-20700000
Annuals > 1 > income Statement > operating Margin
-80.51948051948052
Annuals > 1 > income Statement > total Other Income Expense Net
500000
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
3000000
Annuals > 1 > balance Sheet > short Term Investments
15500000
Annuals > 1 > balance Sheet > receivables
7900000
Annuals > 1 > balance Sheet > inventories
8100000
Annuals > 1 > balance Sheet > total Current Assets
37900000
Annuals > 1 > balance Sheet > property Plant Equipment
9100000
Annuals > 1 > balance Sheet > total Assets
76600000
Annuals > 1 > balance Sheet > payables
2700000
Annuals > 1 > balance Sheet > short Term Debt
3100000
Annuals > 1 > balance Sheet > long Term Debt
4400000
Annuals > 1 > balance Sheet > total Liabilities
16800000
Annuals > 1 > balance Sheet > equity
59800000
Annuals > 1 > balance Sheet > currency_symbol
GBP
Annuals > 1 > cash Flow > net Income
-21700000
Annuals > 1 > cash Flow > depreciation
3400000
Annuals > 1 > cash Flow > change In Working Capital
-5500000
Annuals > 1 > cash Flow > cash From Operations
-21600000
Annuals > 1 > cash Flow > capital Expenditures
1200000
Annuals > 1 > cash Flow > cash From Investing
-18300000
Annuals > 1 > cash Flow > cash From Financing
29800000
Annuals > 1 > cash Flow > net Change In Cash
-10100000
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
-0.06932809912361647
Annuals > 1 > ratios > PB
51.556744651337794
Annuals > 1 > ratios > ROE
-36.2876254180602
Annuals > 1 > ratios > ROA
-28.3289817232376
Annuals > 1 > ratios > FCF
-22800000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-0.7402597402597403
Annuals > 1 > health Score
26
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
27169000
Annuals > 2 > income Statement > cost Of Revenue
17160000
Annuals > 2 > income Statement > gross Profit
10009000
Annuals > 2 > income Statement > operating Expenses
40816000
Annuals > 2 > income Statement > operating Income
-30807000
Annuals > 2 > income Statement > interest Expense
248000
Annuals > 2 > income Statement > pretax Income
-30977000
Annuals > 2 > income Statement > net Income
-26936000
Annuals > 2 > income Statement > eps
-0.14335697020259167
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
187894596
Annuals > 2 > income Statement > income Tax Expense
-4041000
Annuals > 2 > income Statement > EBITDA
-27616000
Annuals > 2 > income Statement > operating Margin
-113.3902609591814
Annuals > 2 > income Statement > total Other Income Expense Net
-200000
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
13097000
Annuals > 2 > balance Sheet > short Term Investments
-153000
Annuals > 2 > balance Sheet > receivables
5000000
Annuals > 2 > balance Sheet > inventories
9325000
Annuals > 2 > balance Sheet > total Current Assets
33687000
Annuals > 2 > balance Sheet > property Plant Equipment
10184000
Annuals > 2 > balance Sheet > total Assets
75337000
Annuals > 2 > balance Sheet > payables
4300000
Annuals > 2 > balance Sheet > short Term Debt
5600000
Annuals > 2 > balance Sheet > long Term Debt
4894000
Annuals > 2 > balance Sheet > total Liabilities
25934000
Annuals > 2 > balance Sheet > equity
49403000
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
-26936000
Annuals > 2 > cash Flow > depreciation
3113000
Annuals > 2 > cash Flow > change In Working Capital
-2820000
Annuals > 2 > cash Flow > cash From Operations
-24988000
Annuals > 2 > cash Flow > capital Expenditures
3274000
Annuals > 2 > cash Flow > cash From Investing
-6027000
Annuals > 2 > cash Flow > cash From Financing
400000
Annuals > 2 > cash Flow > net Change In Cash
-30437000
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
-0.14335697020259167
Annuals > 2 > ratios > PB
37.46253811711839
Annuals > 2 > ratios > ROE
-54.5230046758294
Annuals > 2 > ratios > ROA
-35.754011972868575
Annuals > 2 > ratios > FCF
-28262000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-1.0402296735249734
Annuals > 2 > health Score
22
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
25161000
Annuals > 3 > income Statement > cost Of Revenue
16138000
Annuals > 3 > income Statement > gross Profit
9023000
Annuals > 3 > income Statement > operating Expenses
38982000
Annuals > 3 > income Statement > operating Income
-29959000
Annuals > 3 > income Statement > interest Expense
363000
Annuals > 3 > income Statement > pretax Income
-30339000
Annuals > 3 > income Statement > net Income
-24595000
Annuals > 3 > income Statement > eps
-0.14435256635591667
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
170381453
Annuals > 3 > income Statement > income Tax Expense
-5744000
Annuals > 3 > income Statement > EBITDA
-27540000
Annuals > 3 > income Statement > operating Margin
-119.06919438814039
Annuals > 3 > income Statement > total Other Income Expense Net
-380000
Annuals > 3 > income Statement > currency_symbol
GBP
Annuals > 3 > balance Sheet > cash
43534000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
4460000
Annuals > 3 > balance Sheet > inventories
8504000
Annuals > 3 > balance Sheet > total Current Assets
61167000
Annuals > 3 > balance Sheet > property Plant Equipment
8603000
Annuals > 3 > balance Sheet > total Assets
100609000
Annuals > 3 > balance Sheet > payables
3538000
Annuals > 3 > balance Sheet > short Term Debt
5381000
Annuals > 3 > balance Sheet > long Term Debt
3789000
Annuals > 3 > balance Sheet > total Liabilities
27291000
Annuals > 3 > balance Sheet > equity
73318000
Annuals > 3 > balance Sheet > currency_symbol
GBP
Annuals > 3 > cash Flow > net Income
-24595000
Annuals > 3 > cash Flow > depreciation
2562000
Annuals > 3 > cash Flow > change In Working Capital
-4262000
Annuals > 3 > cash Flow > cash From Operations
-25980000
Annuals > 3 > cash Flow > capital Expenditures
6122000
Annuals > 3 > cash Flow > cash From Investing
-7874000
Annuals > 3 > cash Flow > cash From Financing
31993000
Annuals > 3 > cash Flow > net Change In Cash
-1558000
Annuals > 3 > cash Flow > currency_symbol
GBP
Annuals > 3 > ratios > PE
-0.14435256635591667
Annuals > 3 > ratios > PB
22.89011309705666
Annuals > 3 > ratios > ROE
-33.545650454185875
Annuals > 3 > ratios > ROA
-24.446123110258526
Annuals > 3 > ratios > FCF
-32102000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-1.2758634394499424
Annuals > 3 > health Score
27
Valuation > metrics > PE
0.040660354764915516
Valuation > metrics > PB
73.98224920985221
Valuation > final Score
40
Valuation > verdict
1133.2% Overvalued
Profitability > metrics > ROE
27.750410509031198
Profitability > metrics > ROA
53.31230283911672
Profitability > metrics > Net Margin
7.681818181818182
Profitability > final Score
100
Profitability > verdict
Adequate
Risk > metrics > Debt Equity
0.1297208538587849
Risk > metrics > Interest Coverage
-100
Risk > final Score
-340
Risk > verdict
High
Liquidity > metrics > Current Ratio
5.372881355932203
Liquidity > metrics > Quick Ratio
4.830508474576271
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
33
Prev Risks > 1
-97
Prev Risks > 2
-476
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:00:49.040Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-05-18
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-10-06
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-09-29
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.0004
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-19
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
0
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-06-30
Earnings History > 4 > report Date
2024-09-30
Earnings History > 4 > date
2024-06-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.03
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.03
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2023-03-31
Earnings History > 5 > report Date
2023-04-26
Earnings History > 5 > date
2023-03-31
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
GBP
Earnings History > 5 > eps Actual
-0.07
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2022-06-30
Earnings History > 6 > report Date
2022-09-09
Earnings History > 6 > date
2022-06-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
GBP
Earnings History > 6 > eps Actual
-0.07
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2022-03-31
Earnings History > 7 > report Date
2022-06-02
Earnings History > 7 > date
2022-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
GBP
Earnings History > 7 > eps Actual
-0.09
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2021-06-30
Earnings History > 8 > report Date
2021-09-29
Earnings History > 8 > date
2021-06-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
GBP
Earnings History > 8 > eps Actual
-0.06
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2021-03-31
Earnings History > 9 > report Date
2021-06-05
Earnings History > 9 > date
2021-03-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
GBP
Earnings History > 9 > eps Actual
-0.07
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2020-06-30
Earnings History > 10 > report Date
2020-09-23
Earnings History > 10 > date
2020-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
GBP
Earnings History > 10 > eps Actual
-0.06
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.06
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2020-03-31
Earnings History > 11 > report Date
2020-05-27
Earnings History > 11 > date
2020-03-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
GBP
Earnings History > 11 > eps Actual
-0.07
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.07
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2019-06-30
Earnings History > 12 > report Date
2019-09-30
Earnings History > 12 > date
2019-06-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
GBP
Earnings History > 12 > eps Actual
-0.06
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.06
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2019-03-31
Earnings History > 13 > report Date
2019-05-13
Earnings History > 13 > date
2019-03-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
GBP
Earnings History > 13 > eps Actual
-0.06
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.06
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2018-06-30
Earnings History > 14 > report Date
2018-09-28
Earnings History > 14 > date
2018-06-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
GBP
Earnings History > 14 > eps Actual
-0.05
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.05
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2017-12-31
Earnings History > 15 > report Date
2018-03-20
Earnings History > 15 > date
2017-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
GBP
Earnings History > 15 > eps Actual
-0.05
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.05
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2017-09-30
Earnings History > 16 > report Date
2017-11-24
Earnings History > 16 > date
2017-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
GBP
Earnings History > 16 > eps Actual
-0.04
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.04
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2016-12-31
Earnings History > 17 > report Date
2017-02-03
Earnings History > 17 > date
2016-12-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
GBP
Earnings History > 17 > eps Actual
-0.05
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-0.05
Earnings History > 17 > surprise Percent
-
Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develps CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices delivered through an endoscope. The company also offers Speedboat Inject, an energy multimodal instrument for endoscopy; MicroBlate Fine, a microwave needle ablation device; MicroBlate Flex, a microwave ablation device designed for soft tissue ablation; and SpydrBlade Flex, a multi-modal endoscopic scissor-type device. In addition, it provides endotherapy accessories comprising injection needles, haemostatic clips, snares, and forceps, as well as other products for gastroenterology, pulmonology, and urology. Further, the company offers products for diagnostic, therapeutic, and hygiene purposes. Creo Medical Group PLC was founded in 2003 and is headquartered in Chepstow, the United Kingdom.
Stock Price
GBp 0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAt a 52-week low, is this penny stock the bargain of the year? Fool UK
Read more →1 penny stock down nearly 50% in my Stocks and Shares ISA! Fool UK
Read more →Showing 2 of 10
(Last Updated 2025-06-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very High
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Creo Medical Group PLC
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2026-03-31
EPS Estimate
—
Date
2025-09-30
EPS Actual
0
EPS Estimate
0
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-06-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.